Environmental pesticides increase the risk of developing hypertrophic pyloric stenosis

Troy A Markel1, Cathy Proctor2, Jun Ying3

  • 1Pediatric Surgery, Indiana University School of Medicine/Riley Hospital, Indianapolis, IN, United States.

Insights

Agricultural pesticide use was linked to a higher incidence of hypertrophic pyloric stenosis (HPS) in infants. This study suggests a correlation between environmental factors and this common infant condition.

Area of Science:

  • Environmental Health
  • Pediatric Epidemiology
  • Toxicology

Background:

  • Hypertrophic pyloric stenosis (HPS) is a congenital condition affecting infants, characterized by thickening of the pyloric muscle.
  • The exact causes of HPS remain unclear, with suspected genetic and environmental factors.
  • This study investigated a potential link between agricultural pesticide exposure and HPS incidence.

Purpose of the Study:

  • To determine if agricultural pesticide use is associated with an increased incidence of hypertrophic pyloric stenosis (HPS).
  • To explore correlations between pesticide types and HPS rates in specific geographic areas.

Main Methods:

  • Utilized data from the Indiana Birth Defects Registry (IBDR) and live birth records (2005-2009).
  • Correlated infant HPS incidence with estimated agricultural pesticide use (EPEST) data from the USGS.
  • Employed univariate and multivariate logistic regression models to analyze the association.

Main Results:

  • A total of 1313 HPS cases were identified among 442,329 live births, with an overall incidence of 30/10,000.
  • HPS incidence showed a positive correlation with total county pesticide use, including fungicides, fumigants, insecticides, and herbicides.
  • Infants in high pesticide-use counties had a higher HPS incidence (36/10,000) compared to low-use counties (26/10,000).
  • The association was more pronounced in male infants born to mothers who were white, aged 20-35, had lower educational attainment, and smoked.

Conclusions:

  • Significant correlation found between agricultural pesticide use and the incidence of hypertrophic pyloric stenosis.
  • Pesticide exposure may be a contributing environmental factor to HPS development.
  • Further research is warranted to confirm these findings and understand the mechanisms involved.
Abstract

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.6K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
35
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.1K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.8K
Esophageal Strictures-I: Introduction01:30

Esophageal Strictures-I: Introduction

Esophageal strictures involve abnormal narrowing or tightening of the esophagus. They vary in length and severity, ranging from mild constriction to complete obstruction, and are classified as benign (noncancerous) or malignant (cancerous).
Etiology
The primary cause of esophageal strictures is long-standing gastroesophageal reflux disease (GERD), accounting for about 70 to 80% of adult cases. Chronic acid reflux can lead to injury and scarring of the esophageal lining, culminating in...
1.3K
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents01:20

Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents

The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
1.7K